Biotechnology - Mergers & Acquisitions, Antibiotics and Infectious diseases


Popular Filters

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology


UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

Official: Merck & Co to acquire Cubist for $8.4 billion

Official: Merck & Co to acquire Cubist for $8.4 billion


Confirming weekend speculation and rumors, US pharma giant Merck & Co this morning said it has entered…

Antibiotics and Infectious diseasesBiotechnologyCubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsZerbaxa

Terms amended in Bellus' acquisition of Thallion


Canada-based drugmaker Bellus Health (TSX: BLU) has amended its agreement to acquire fellow Canadian…

Antibiotics and Infectious diseasesBellus HealthBiotechnologyMergers & AcquisitionsNorth AmericaShigamabsThallion Pharmaceuticals

Synthetic Biologics to acquire clinical-stage C. diff infectious disease program


USA-based Synthetic Biologics (NYSE: SYN), a developer of synthetic biologics and innovative medicines…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsPrev AbRSYN-004Synthetic Biologics

Forest acquires rights to Nabriva antibacterial and option to buy firm


US drugmaker Forest Laboratories (NYSE: FRX) says it has entered into an agreement with Austrian biotech…

Antibiotics and Infectious diseasesBC-3781BiotechnologyForest LaboratoriesLicensingMergers & AcquisitionsNabriva TherapeuticsPharmaceutical

Back to top